DARE RH1
Alternative Names: CatSper; DARE-RH1Latest Information Update: 09 Mar 2023
Price :
$50 *
At a glance
- Originator Hydra Biosciences
- Developer Dare Bioscience
- Class Contraceptives
- Mechanism of Action CATSPER ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pregnancy
Most Recent Events
- 06 Feb 2023 DARE RH1 is still in preclinical development in Pregnancy (Prevention) in USA
- 28 Dec 2022 No recent reports of development identified for preclinical development in Pregnancy(Prevention) in USA
- 30 Nov 2018 Preclinical trials in Pregnancy (Prevention) in USA (unspecified route), before November 2018